Download video

IMPACT Alumni Hubly Surgical Testimonial

95 views

UMass Lowell's M2D2

13 days ago

IMPACT Alumni Hubly Surgical Testimonial

IMPACT Alumni Hubly Surgical Testimonial

About IMPACT
1:29
About IMPACT
by IMPACT
AI-Powered Biomarkers and Precision Medicine in High-Risk NMIBC
12:02
AI-Powered Biomarkers and Precision Medicine in High-Risk NMIBC
by GU Oncology Now
Genotype-Guided P2Y12 Inhibitor Monotherapy in High Bleeding Risk Patients
4:52
Genotype-Guided P2Y12 Inhibitor Monotherapy in High Bleeding Risk Patients
by Mayo Proceedings
Drop Impact 2
0:12
Drop Impact 2
by Imperial Faculty of Natural Sciences
doppler bistos mati total, begini servisnya.
8:10
doppler bistos mati total, begini servisnya.
by piluzian
Mezagitamab in Patients With Immune Thrombocytopenia
13:48
Mezagitamab in Patients With Immune Thrombocytopenia
by CheckRare
Pharmacology of pertuzumab (Perjeta) ; Mechanism of action, Pharmacokinetics, Uses, Effects
2:05
Pharmacology of pertuzumab (Perjeta) ; Mechanism of action, Pharmacokinetics, Uses, Effects
by MBBS NAIJA
Inluriyo: A New Treatment Option for ER+, HER2- Breast Cancer Patients
5:06
Inluriyo: A New Treatment Option for ER+, HER2- Breast Cancer Patients
by Phim ngắn
Hi Dop Vascular Doppler with 2MHz Probe BT200 2MHZ
0:13
Hi Dop Vascular Doppler with 2MHz Probe BT200 2MHZ
by Medisave Medical Supplies
The getah virus nsP2 protein is critical for immune evasion and pathogenicity
1:45
The getah virus nsP2 protein is critical for immune evasion and pathogenicity
by AJE Video Bytes
Enhanced pathologic response with neoadjuvant pembrolizumab plus vidutolimod in high-risk resect...
3:31
Enhanced pathologic response with neoadjuvant pembrolizumab plus vidutolimod in high-risk resect...
by ecancer
Could A New Treatment Stop Aggressive Cancer Cells?
2:05
Could A New Treatment Stop Aggressive Cancer Cells?
by Institute for Translational Medicine
Ropeginterferon Alfa-2b shows superior efficacy and safety over anagrelide in essential thromboc...
3:56
Ropeginterferon Alfa-2b shows superior efficacy and safety over anagrelide in essential thromboc...
by ecancer